Clinical Trial Update: Duloxetine Tibial Plateau [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial of duloxetine for tibial plateau fracture-related pain was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tibial Plateau Fracture

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Boston Medical Center | Conditions: Tibial Plateau Fracture, Pain, Postoperative | Phase 4 | Status: WITHDRAWN